Found 0 matching trials
S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer PHASE3 RATIONALE: Drugs used in chemotherapy, such as doxorubicin, cyclophosphamid...
Show More Status
Active Not Recruiting
Location
Regional Medical Center
Learn More & Join Trial
A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer PHASE1 Background:
* PSA (prostate specific antigen) is a protein found on normal...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma PHASE2 RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...
Show More Location
Knight Cancer Institute at Oregon Health and Science University
Learn More & Join Trial
Diagnostic Performance of a Commercial Assay for the Detection of Neuronal Antibodies N/A Detection of autoantibodies targeting neuronal surface or intracellular ant...
Show More Location
Hospice Civils de Lyon
Learn More & Join Trial
A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma EARLY_PHASE1 The purpose of this study is to determine if the combination of G-CSF and b...
Show More Location
University of Kansas Medical Center
Learn More & Join Trial
Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma PHASE1 Monoclonal antibodies can locate tumor cells and either kill them or delive...
Show More Location
Children's Oncology Group
Learn More & Join Trial
T-VEC in Non-melanoma Skin Cancer PHASE1 Evaluation of the mechanism of Action of talimogene laherparepvec (T-VEC) i...
Show More Location
Department of Dermatology, University Hospital Zurich
Learn More & Join Trial
A Study of LY2523355 in Participants With Breast Cancer PHASE2 The purpose of the study is to evaluate the anti-tumor activity of LY252335...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial
Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer PHASE2 The main purpose of this study is to see if pegfilgrastim (Neulasta) is saf...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Phase 2a Trial of Alpibectir Plus Ethionamide for Tuberculosis Meningitis PHASE2 AlpE is a novel drug combination under development for the treatment of TB,...
Show More Location
Multiple Locations
Learn More & Join Trial